Frequently asked questions

Your questions about Cystoplus®, answered.

  • *ACE inhibitor = Angiotensin-converting enzyme inhibitors

Reference:

  1. Health Canada. Cystoplus Sodium Citrate Powder Product Licence. Issued, August 10, 2012.

Disclaimers

  • Cystoplus® is recommended for symptomatic relief of burning and stinging associated with cystitis in adult women.1
  • If patients have more than just mild symptoms (for example: painful urination, blood in urine or side pain, fever and chills, nausea and vomiting), or if symptoms persist or return soon after completing the 48-hour treatment, they should consult their health care practitioner. Cystoplus® is contraindicated in individuals taking lithium of hexamine, are on a low-sodium diet, are sensitive to any of the ingredients, if they are pregnant or breastfeeding, and in men and children.1
  • Although Cystoplus® Sodium Citrate Powder is not contraindicated for use with antibiotics, patients should always inform their primary care provider if they are taking any other medication. Due to its alkalizing effect on urine, sodium citrate can affect the excretion of certain antibiotics and alter their pharmacokinetic profiles.
  • Always direct the patient to read the label.
  • For more information: See Warnings, Cautions, and Directions of Use at https://health-products.canada.ca/lnhpd-bdpsnh/info?licence=80034529 for information to assist in benefit-risk assessment. The terms of Market Authorization are also available upon request by calling 1-888-550-6060.